NBR has just released a new Q&A with BT Slingsby (Eisai Co., Ltd.) that discusses how emerging economies provide a new outlook and opportunity for the Japanese pharmaceutical industry. A link to the full interview and a summary are below.
"Beyond Borders: New Growth and Direction for Japan's Pharmaceutical Industry"
Q&A with BT Slingsby, Global Partner Solutions, Eisai Co., Ltd.
Link: http://m.nbr.org/wMTDOO

SUMMARY
Looking to the future of the Japanese pharmaceutical industry, BT Slingsby, Director of Global Partner Solutions, Eisai Co., examines the industry's role in emerging markets and trends that are expected to drive market growth for Japan.
In this new NBR interview, Dr. Slingsby discusses the need for innovative business models that facilitate the expansion of Japanese pharma into emerging markets and discusses the challenges and opportunities awaiting Japanese pharma in the developing world.
Read this Expert Interview to learn:
- What key factors are driving Japanese companies to expand their focus from domestic and developed country markets to emerging markets?
- Are product development partnerships a viable model for pharma companies to use to improve access to critical medicines in the developing world?
- How has Japan's unique approach to innovation paved the way for Japanese pharma to effectively globalize?
Link: http://m.nbr.org/wMTDOO
Tracy Timmons-Gray
The National Bureau of Asian Research (NBR) Seattle, WA

This e-mail and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you have received this e-mail in error please notify the NBR system manager. If you are not the named addressee please notify the sender immediately by e-mail and please delete this e-mail from your system. If you are not the intended recipient you are hereby notified that disclosing, copying, distributing, or taking any action in reliance on the contents of this information is strictly prohibited.
Warning: Although having taken reasonable precautions to ensure no viruses are present in this e-mail, The National Bureau of Asian Research cannot accept responsibility for any loss or damage arising from the use of this e-mail or attachments.